Postpartum Hemorrhage Treatment Devices Market USD 826 Million by 2020 - iHealthcareAnalyst, Inc.
The global postpartum hemorrhage treatment devices market to reach nearly USD 826 Million in 2020, at a CAGR of 5.5% from 2016 to 2020.
Maryland Heights, MO, October 10, 2016 --(PR.com)-- Postpartum Hemorrhage Treatment Devices Market 2013-2020 report estimates the global postpartum hemorrhage treatment devices market to reach nearly USD 826 Million in 2020, at a CAGR of 5.5% from 2016 to 2020 - iHealthcareAnalyst, Inc.
Visit the Postpartum Hemorrhage Treatment Devices Market 2013-2020 report https://www.ihealthcareanalyst.com/report/postpartum-hemorrhage-treatment-devices-market/.
The global postpartum hemorrhage treatment devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
Postpartum Hemorrhage is defined as the loss of more than 500 ml or 1000 ml of blood within the first 24 hours following childbirth. It is generally caused by four major conditions- tone (uterine atony), trauma, tissue (retained placenta), Thrombin (coagulopathy). The treatment devices have been available in the market for more than two decades.
The global postpartum hemorrhage treatment devices market segmentation is based on product type (non-pneumatic anti-shock garment, uniject prefilled injection system, uterine balloon tamponade, foley catheters, condom catheters, etc.). The global postpartum hemorrhage treatment devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global postpartum hemorrhage treatment devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Product Type
1.1 Non-pneumatic Anti-Shock Garment (NASG)
1.2 Uniject Prefilled Injection System
1.3 Uterine Balloon Tamponade
1.3.1 Foley Catheters
1.3.2 Condom Catheters
1.3.3 Others
2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World
3. Company Profiles
3.1 3rd Stone Design, Inc.
3.2 Bactiguard AB
3.3 Cook Medical, Inc.
3.4 C.R. Brad, Inc.
3.5 Program for Appropriate Technology in Health (PATH)
3.6 Teleflex Incorporated
3.7 Utah Medical Products, Inc.
3.8 Zoex Niasg
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Visit the Postpartum Hemorrhage Treatment Devices Market 2013-2020 report https://www.ihealthcareanalyst.com/report/postpartum-hemorrhage-treatment-devices-market/.
The global postpartum hemorrhage treatment devices market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).
Postpartum Hemorrhage is defined as the loss of more than 500 ml or 1000 ml of blood within the first 24 hours following childbirth. It is generally caused by four major conditions- tone (uterine atony), trauma, tissue (retained placenta), Thrombin (coagulopathy). The treatment devices have been available in the market for more than two decades.
The global postpartum hemorrhage treatment devices market segmentation is based on product type (non-pneumatic anti-shock garment, uniject prefilled injection system, uterine balloon tamponade, foley catheters, condom catheters, etc.). The global postpartum hemorrhage treatment devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global postpartum hemorrhage treatment devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
1. Product Type
1.1 Non-pneumatic Anti-Shock Garment (NASG)
1.2 Uniject Prefilled Injection System
1.3 Uterine Balloon Tamponade
1.3.1 Foley Catheters
1.3.2 Condom Catheters
1.3.3 Others
2. Geography (Region, Country)
2.1 North America (U.S., Canada)
2.2 Latin America (Brazil, Mexico, Rest of LA)
2.3 Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
2.4 Asia Pacific (Japan, China, India, Rest of APAC)
2.5 Rest of the World
3. Company Profiles
3.1 3rd Stone Design, Inc.
3.2 Bactiguard AB
3.3 Cook Medical, Inc.
3.4 C.R. Brad, Inc.
3.5 Program for Appropriate Technology in Health (PATH)
3.6 Teleflex Incorporated
3.7 Utah Medical Products, Inc.
3.8 Zoex Niasg
About Us
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareranalyst.com
Website: http://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 736-9294
http://www.ihealthcareanalyst.com/
Contact
Categories